Literature DB >> 20519613

The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia.

Yodi Mahendradhata1, Ari Probandari, Riris A Ahmad, Adi Utarini, Laksono Trisnantoro, Lars Lindholm, Marieke J van der Werf, Michael Kimerling, Marleen Boelaert, Benjamin Johns, Patrick Van der Stuyft.   

Abstract

We aimed to evaluate the incremental cost-effectiveness of engaging private practitioners (PPs) to refer tuberculosis (TB) suspects to public health centers in Jogjakarta, Indonesia. Effectiveness was assessed for TB suspects notified between May 2004 and April 2005. Private practitioners referred 1,064 TB suspects, of which 57.5% failed to reach a health center. The smear-positive rate among patients reaching a health center was 61.8%. Two hundred eighty (280) out of a total of 1,306 (21.4%) new smear-positive cases were enrolled through the PPs strategy. The incremental cost-effectiveness ratio per smear-positive case successfully treated for the PPs strategy was US$351.66 (95% CI 322.84-601.33). On the basis of an acceptability curve using the National TB control program's willingness-to-pay threshold (US$448.61), we estimate the probability that the PPs strategy is cost-effective at 66.8%. The strategy of engaging PPs was incrementally cost-effective, although under specific conditions, most importantly a well-functioning public directly observed treatment, short-course (DOTS) program.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519613      PMCID: PMC2877424          DOI: 10.4269/ajtmh.2010.09-0447

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Private practitioners and public health: weak links in tuberculosis control.

Authors:  M Uplekar; V Pathania; M Raviglione
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

2.  How many sputum smears are necessary for case finding in pulmonary tuberculosis?

Authors:  Mohammed A Yassin; Luis E Cuevas
Journal:  Trop Med Int Health       Date:  2003-10       Impact factor: 2.622

3.  Public-private mix for DOTS implementation: what makes it work?

Authors:  Knut Lönnroth; Mukund Uplekar; Vijay K Arora; Sanjay Juvekar; Nguyen T N Lan; David Mwaniki; Vikram Pathania
Journal:  Bull World Health Organ       Date:  2004-09-13       Impact factor: 9.408

4.  Collaboration between private pharmacies and national tuberculosis programme: an intervention in Bolivia.

Authors:  M L Lambert; R Delgado; G Michaux; A Vols; N Speybroeck; P Van der Stuyft
Journal:  Trop Med Int Health       Date:  2005-03       Impact factor: 2.622

5.  Leadership, management and technical lessons learnt from a successful public-private partnership for TB control in Nepal.

Authors:  J N Newell; S B Pande; S C Baral; D S Bam; P Malla
Journal:  Int J Tuberc Lung Dis       Date:  2005-09       Impact factor: 2.373

6.  Cost and cost-effectiveness of a public-private mix project in Kannur District, Kerala, India, 2001-2002.

Authors:  O Ferroussier; M K A Kumar; P K Dewan; P K J Nair; S Sahu; D F Wares; K Laserson; C Wells; R Granich; L S Chauhan
Journal:  Int J Tuberc Lung Dis       Date:  2007-07       Impact factor: 2.373

7.  Involvement of private practitioners in tuberculosis control in Ballabgarh, Northern India.

Authors:  A Krishnan; S K Kapoor
Journal:  Int J Tuberc Lung Dis       Date:  2006-03       Impact factor: 2.373

8.  Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential.

Authors:  Yodi Mahendradhata; Adi Utarini; Upiek Lazuardi; Marleen Boelaert; Patrick Van der Stuyft
Journal:  Trop Med Int Health       Date:  2007-10       Impact factor: 2.622

9.  Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.

Authors:  Elisabeth Fenwick; Bernie J O'Brien; Andrew Briggs
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

10.  Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa.

Authors:  Edina Sinanovic; Lilani Kumaranayake
Journal:  Cost Eff Resour Alloc       Date:  2006-06-06
View more
  12 in total

Review 1.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

2.  How do private general practitioners manage tuberculosis cases? A survey in eight cities in Indonesia.

Authors:  Yodi Mahendradhata; Trisasi Lestari; Ari Probandari; Lucia Evi Indriarini; Erlina Burhan; Dyah Mustikawati; Adi Utarini
Journal:  BMC Res Notes       Date:  2015-10-14

3.  Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?

Authors:  Niranjan Konduri; Emily Delmotte; Edmund Rutta
Journal:  J Pharm Policy Pract       Date:  2017-01-18

4.  Feasibility study of strengthening the public-private partnership for tuberculosis case detection in Bandung City, Indonesia.

Authors:  Bony Wiem Lestari; Nita Arisanti; Adiatma Y M Siregar; Estro Dariatno Sihaloho; Gelar Budiman; Philip C Hill; Bachti Alisjahbana; Susan McAllister
Journal:  BMC Res Notes       Date:  2017-08-14

5.  Patients' willingness to pay for the treatment of tuberculosis in Nigeria: exploring own use and altruism.

Authors:  Ogbonnia G Ochonma; Obinna E Onwujekwe
Journal:  Int J Equity Health       Date:  2017-05-10

6.  Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.

Authors:  Ahmad Fuady; Tanja A J Houweling; Muchtaruddin Mansyur; Jan Hendrik Richardus
Journal:  Infect Dis Poverty       Date:  2018-01-12       Impact factor: 4.520

7.  The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan.

Authors:  Hamidah Hussain; Amani Thomas Mori; Aamir J Khan; Saira Khowaja; Jacob Creswell; Thorkild Tylleskar; Bjarne Robberstad
Journal:  BMC Health Serv Res       Date:  2019-10-12       Impact factor: 2.655

8.  A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.

Authors:  Lucy Cunnama; Gabriela B Gomez; Mariana Siapka; Ben Herzel; Jeremy Hill; Angela Kairu; Carol Levin; Dickson Okello; Willyanne DeCormier Plosky; Inés Garcia Baena; Sedona Sweeney; Anna Vassall; Edina Sinanovic
Journal:  Pharmacoeconomics       Date:  2020-08       Impact factor: 4.981

Review 9.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Authors:  Tadayuki Tanimura; Ernesto Jaramillo; Diana Weil; Mario Raviglione; Knut Lönnroth
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

10.  Collaborative Approaches and Policy Opportunities for Accelerated Progress toward Effective Disease Prevention, Care, and Control: Using the Case of Poverty Diseases to Explore Universal Access to Affordable Health Care.

Authors:  Samia Laokri
Journal:  Front Med (Lausanne)       Date:  2017-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.